Annexin Pharma: Directed Share Issue (As Expected) - Redeye

Yesterday evening, Annexin announced that it had decided on a directed share issue of SEK 10.9 million at SEK 0.88/share. This was expected and included in our valuation, as a group of major shareholders had committed to guarantee SEK 17 million in proceeds in relation to the company’s TO3 warrant program (which brough in SEK 6.1 million). We thus reiterate our base case of SEK 2.2 per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/846887/annexin-pharma-directed-share-issue-as-expected?utm_source=finwire&utm_medium=RSS